Abnormal κ:λ light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis

Scandinavian Journal of Immunology

Volumn 65, Issue 1, 2007, Pages 76-83

  Low, J M ^a   Chauhan, A K ^a,b   Moore, T L ^a,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Progen Biologics LLC   (United States)

^c Doisy Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; RHEUMATOID FACTOR;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; POLYARTHRITIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, JUVENILE RHEUMATOID; B-LYMPHOCYTES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS;

EID: 33845695293     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01859.x     Document Type: Article

References (38)

1. Nemazee D, Weigert M. Revising B cell receptors. J Exp Med 2000;191:1813-7.
2. Nemazee D. Receptor selection in B and T lymphocytes. Annu Rev Immunol 2000;18:19-51.
3. Xu H, Li H, Surey-Payer E, Hardy RR, Weigert M. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med 1998;188:1247-54.
4. Brown CMS, Plater-Zyberk C, Mageed RA, Jefferis R, Maini RN. Analysis of immunoglobulins secreted by hybridomas derived from rheumatoid synovia. Clin Exp Immunol 1990;80:366-72.
5. Gharavi AE, Harris EN, Lockshin MD, Hughes GR, Elkon KB. IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. Ann Rheum Dis 1988;47:286-90.
6. Wardemann H, Hammersen J, Nussenzweig MC. Human autoantibody silencing by immunoglobulin light chains. J Exp Med 2004;200:191-9.
7. Low JM, Chauhan AK, Moore TL. Reversal of the κ to λ light chain ratio in circulating immune complexes from patients with juvenile idiopathic arthritis. Arthritis Rheum 2004;50:S362.
8. Chauhan AK, Moore TL. Presence of complement regulatory proteins clusterin (Apo J) and vitronectin (S 40) on circulating immune complexes (CIC). Clin Exp Immunol 2006;145:398-406.
9. Moore TL, Sheridan PW, Traycoff RB, Zuckner J, Dorner RW. Immune complexes in juvenile rheumatoid arthritis: a comparison of four methods. J Rheumatol 1982;9:395-401.
10. Melsom RD, Horsfall AC, Schreiber L, Charles P, Maini RN. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease. Rheumatol Int 1986;6:227-31.
11. Nydegger UE. Immune complexes. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB, eds. Kelley's Textbook of Rheumatology. Philadelphia, PA: Elsevier Saunders, 2005:332-41.
12. Moore TL, Sheridan PW, Zuckner J, Dorner RW. Separation and characterization of immune complexes containing 19S IgM rheumatoid factor-IgG in juvenile arthritis. Arthritis Rheum 1983;26:165-9.
13. Moore TL, Dorner RW, Sheridan PW, Zuckner J. Precipitation of 19S IgM rheumatoid factor IgG circulating immune complexes in patients with juvenile rheumatoid arthritis by polyethylene glycol and separation by immobilized protein A. Clin Exp Immunol 1984;56:247-52.
14. Moore TL, Dorner RW. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients. Rheumatol Int 1986;6:59-62.
15. Moore TL, Osborn TG, Dorner RW. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in sera of patients with juvenile rheumatoid arthritis. Pediatr Res 1986;20:977-81.
16. Prak EL, Weigert M. Light chain replacement: a new model for antibody gene rearrangement. J Exp Med 1995;182:541-8.
17. Retter MW, Nemazee D. Receptor editing occurs frequently during normal B cell development. J Exp Med 1998;188:1231-8.
18. Ait-Azzouzene D, Skog P, Retter MW et al. Tolerance-induced receptor selection: scope, sensitivity, locus specificity, and relationship to lymphocyte-positive selection. Immunol Rev 2004;197:219-30.
19. κJκ-joints and κ/λ ratios in naïve versus memory B-cell subsets to identify traces of receptor editing processes. Curr Top Microbiol Immunol 1999;246:141-6.
20. de Wildt RM, Hoet RMA, van Venrooij WJ, Tomlinson IM, Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 1999;285:895-901.
21. Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002;195:181-8.
22. Verkoczy LK, Martensson AS, Nemazee D. The scope of receptor editing and its association with autoimmunity. Curr Opin Immunol 2004;16:808-14.
23. Lam CWK, Chui SH, Leung NWY, Li EK, Lai KN. Light chain ratios of serum immunoglobulins in disease. Clin Biochem 1991;24:283-7.
24. Renckens ALJM, Jansen MJH, van Munster PJ, Weemaes CM, Bakkeren JA. Nephelometry of the kappa/lambda light-chain ratio in serum of normal and diseased children. Clin Chem 1986;32:2147-9.
25. Lindstrom LD. Kappa:lambda light chain ratio in IgG eluted from rheumatoid arthritis synovium. Clin Exp Immunol 1970;7:1-10.
26. Schrauder A, Gause A, Jung W, Mierau R, Pfreundschuh M. Persistence of a rheumatoid factor producing B cell clone with a somatically mutated Igκ chain in a patient with rheumatoid arthritis. Clin Exp Immunol 1994;97:200-3.
27. L/λ genes. Clin Exp Immunol 1999;115:168-75.
28. Semrad TJ, Kenny TP, Malyj W, Robbins DL. Mutational analysis of immunoglobulin germline derived light chains in rheumatoid arthritis. Clin Immunol 2001;99:276-82.
29. Normansell DE. Use of kappa and lambda chain quantitation for the detection of immunoglobulin abnormalities in serum. Diagn Clin Immunol 1987;5:100-3.
30. Horsfall AC, Isenberg DA. Idiotypes and autoimmunity: a review of their role in human disease. J Autoimmun 1988;1:718-24.
31. Suen KK, Lewis WH, Lai KN. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay. Scand J Urol Nephrol 1997;31:289-93.
32. Meffre E, Davis E, Schiff C et al. Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol 2000;1:207-13.
33. Meffre E, Schaefer A, Wardeman H, Wilson P, Davis E, Nussenzweig MC. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med 2004;199:145-50.
34. Bridges SL Jr, Lee SK, Johnson ML et al. Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals. J Clin Invest 1995;96:831-41.
35. Meffre E, Chiorazzi M, Nussenzweig MC. Circulating human B cells that express surrogate light chains display a unique antibody repertoire. J Immunol 2001;167:2151-6.
36. Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994;180:885-95.
37. Leung JC, Tang SC, Chan DT, Lui SL, Lai KN. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy. J Clin Lab Anal 2002;16:11-9.
38. White KD, Frank MB, Foundling S, Waxman FJ. Effect of immunoglobulin variable region structure on C3b and C4b deposition. Mol Immunol 1996;33:759-68.